The tweet was deleted by the author.
But we saved everything 🙂.
Libertex has expanded its range of tradable instruments with the launch of several new equity-based contracts for difference (CFDs), as the platform continues to broaden market access for retail traders.
The update introduces CFDs linked to MetLife Inc. (MET), Zymeworks Inc. (ZYME) and Jazz Pharmaceuticals Plc (JAZZ), adding exposure to the insurance and biotechnology sectors.
The move reflects growing demand among traders for diversified equity exposure through derivatives, particularly in sectors sensitive to macroeconomic shifts, interest rates and healthcare innovation.
The newly added CFDs allow traders to speculate on price movements in large-cap financial services and healthcare-focused companies without owning the underlying shares. MetLife, a major global insurance provider, offers exposure to interest-rate dynamics and financial stability trends. Zymeworks and Jazz Pharmaceuticals represent biotechnology and pharmaceutical innovation, sectors known for heightened volatility driven by research outcomes, regulatory decisions and earnings results.
By expanding its equity CFD lineup, Libertex aims to provide users with more tools to diversify strategies and respond to sector-specific developments across global markets.
The new CFDs are available directly through the Libertex trading platform, with no separate enrollment required beyond standard account access.
How to start trading new CFDs on Libertex:
1. Register or log in to a Libertex account
2. Fund the trading account
3. Select the desired equity CFD
4. Execute trades via the Libertex platform
Libertex is an online trading platform offering access to CFDs across a wide range of asset classes, including equities, forex, commodities, indices and cryptocurrencies. The platform emphasizes a streamlined user experience, transparent pricing structures and fast order execution. Its interface is designed to support both new and experienced traders, with built-in analytical tools and risk-management features.
The addition of new equity CFDs highlights Libertex’s ongoing efforts to expand instrument coverage and align its offering with evolving trader interest. Market participants will be watching whether further listings follow, particularly as volatility continues to drive demand for flexible trading instruments across global equity markets.
We have previously highlighted that Libertex anniversary promotion offers up to 28% APR.